10.1002/ejoc.202000029
European Journal of Organic Chemistry
FULL PAPER
= 8.6 Hz, 2H, Z), 7.57 (d, J = 8.8 Hz, 2H, Z), 7.57 (d, J = 8.8 Hz,
2H, E), 7.52 (d, J = 8.8 Hz, 2H, E), 7.24 (dd, J = 13.5, J = 1.1
Hz, 1H, E), 7.18 (dd, J = 7.6, J = 1.2 Hz, 1H, Z), 6.85 (ddd, J =
9.2, J = 5.0 Hz, J = 1.2 Hz, 1H, Z), 6.72 (dd, J = 13.5, J = 4.9 Hz,
1H, E), 6.12 (t, J = 8.2 Hz, 1H, Z), 5.85 (ddd, J = 4.9, J = 2.8, J =
1.1 Hz, 1H, E), 5.84 (dd, J =7.5 Hz, J = 4.0 Hz, 1H, Z), 5.41 (dd,
J = 8.5, J = 3.2, 1H, E), 5.21 (ddd, J = 7.9, J = 4.7, J = 2.7 Hz,
1H, E), 5.39 (dd, J = 12.5 Hz, J = 3.0 Hz, 1H, Z), 4.32 (dd, J =
12.5, J = 5.5 Hz, 1H, Z), 4.23 (dd, J = 12.5, J = 2.7 Hz, 1H, E),
4.13 (dd, J = 12.5, J = 4.8 Hz, 1H, E), 4.13 (m, 1H, Z), 2.07 (s,
3H, E), 2.03 (s, 3H, E), 2.00 (s, 3H, E), 1.89 (s, 3H, Z); 13C NMR
(125 MHz, CDCl3) 170.4, 169.8, 169.7, 169.5, 151.3, 150.9,
149.8, 147.4, 137.1, 132.6, 132.4, 132.3, 132.2, 131.9, 129.0,
126.2, 125.8, 124.5, 124.3, 123.2, 71.6, 69.9, 69.2, 68.9, 68.3,
67.3, 61.8, 61.7, 20.8, 20.7, 20.6, 20.5.
= 5.0, J(5,6) = 3.0 Hz, 1H, H-5, Z), 4.27 (dd, J(6,6’) = 12.5, J(5,6)
= 3.0 Hz, 1H, H-6, E), 4.21 (dd, J(6,6’) = 12.0, J(5,6) = 3.0 Hz,
1H, H-6, Z), 4.18 (dd, J(6,6’) = 12.5, J(5,6’) = 5,0 Hz, 1H, H-6’,
E), 4.11 (dd, J(6,6’) = 12.0, J(5,6’) = 5.0 Hz, 1H, H-6’, Z), 1.78 (s,
3H, CH3, E), 1.70 (s, 3H, CH3, E), 1.56 (s, 3H, CH3, E); 13C NMR
(125 MHz, C6D6) 169.9 (E), 169.5 (E), 169.4 (E), 169.2 (Z),
154.1 (Z), 152.9 (E), 150.5 (E), 141.7 (Z), 138.5 (Z), 137.4 (E),
131.5 (E), 129.3 (E), 129.2 (Z), 127.3 (Z), 123.5 (Z), 123.3 (E),
119.5 (Z), 72.1 (Z), 70.3 (E), 70.2 (Z), 70.1 (Z), 69.6 (Z), 69.5
(E), 68.7 (E), 62.0 (E), 61.9 (Z) 20.4 (E), 20.3 (Z), 20.2 (E), 20.1
(E), 20.0 (Z), 19.9 (E).
Mixture of Compounds (1E,3E)-4-(tetra-O-acetyl-D-arabino-
tetritol-1-yl)-1-(4-methoxyphenyl)-1,2-diaza-1,3-butadiene
(5a) and (1Z,3E)-4-(tetra-O-acetyl-D-arabino-tetritol-1-yl)-1-
(4-methoxyphenyl)-1,2-diaza-1,3-butadiene (5c): E/Z ratio
1
Mixture of Compounds (1E,3E)-4-(tetra-O-acetyl-D-lyxo-
after equilibration (%) = 94:6. H NMR (500 MHz, C6D6) 7.89
tetritol-1-yl)-1-phenyl-1,2-diaza-1,3-butadiene
(9a)
and
(d, J = 9.0 Hz, 2H, arom, E), 7.65 (dd, J(1,2) = 14.0, J(1,3) = 1.0
Hz, 1H, H-1, E), 7.38 (dd, J(1,2) = 13.5, J(1,3) = 1.0 Hz, 1H, H-1,
Z), 6.87 (dd, J(1,2) = 13.5, J(2,3) = 6.5 Hz, 1H, H-2, Z), 6.86 (m,
1H, arom, Z), 6.84 (dd, J(1,2) = 14.0, J(2,3) = 6.0 Hz, 1H, H-2,
E), 6.66 (d, J = 9.0 Hz, 2H, arom, E), 6.60 (m, 1H, arom, Z), 6.06
(ddd, J(2,3) = 6.0, J(3,4) = 3.0, J(1,3) = 1.5 Hz, 1H, H-3, E), 5.79
(ddd, J(2,3) = 6.5, J(3,4) = 3.5, J(1,3) = 1.0 Hz, 1H, H-3, Z), 5.64
(dd, J(4,5) = 9.0, J(3,4) = 3.0 Hz, 1H, H-4, E), 5.56 (dd, J(4,5) =
8.5, J(3,4) = 3.5 Hz, 1H, H-4, Z), 5.47 (ddd, J(4,5) = 9.0, J(5,6’) =
5.0, J(5,6) = 3.0 Hz, 1H, H-5, E), 5.41 (ddd, J(4,5) = 8.5, J(5,6’)
= 5.0, J(5,6) = 2.5, Hz, 1H, H-5, Z), 4.28 (dd, J(6,6’) = 12.5,
J(5,6) = 3.0 Hz, 1H, H-6, E), 4.24 (dd, J(6,6’) = 12.5, J(5,6) = 3.0
Hz, 1H, H-6, Z), 4.19 (dd, J(6,6’) = 12.5, J(5,6’) = 5.0 Hz, 1H, H-
6’, E), 4.14 (dd, J(6,6’) = 12.5, J(5,6’) = 6.0 Hz, 1H, H-6’, Z), 3.17
(s, 3H, CH3, Z), 3.10 (s, 3H, CH3, E), 1.78 (s, 3H, CH3, E), 1.73
(s, 3H, CH3, E), 1.72 (s, 3H, CH3, Z), 1.71 (s, 3H, CH3, E), 1.69
(s, 3H, CH3, Z), 1.63 (s, 3H, CH3, Z), 1.62 (s, 3H, CH3, Z) , 1.59
(s, 3H, CH3, E); 13C NMR (125 MHz, C6D6) 169.4 (E), 169.5
(E), 169.4 (E), 162.8 (E) 150.8 (E), 147.4 (E), 142.5 (Z), 135.9
(Z), 135.0 (E), 125.6 (Z), 125.3 (E), 122.7 (Z), 114.6 (Z), 114.5
(E), 114.2 (Z), 70.4 (E), 69.9 (Z), 69.7 (E), 68.8 (E), 62.1 (E),
61.9 (Z), 55.0 (E), 54.9 (Z), 20.4 (E), 20.3 (Z), 20.2 (E), 20.1 (E),
19.9 (E).
(1E,3Z)-4-(tetra-O-acetyl-D-lyxo-tetritol-1-yl)-1-phenyl-1,2-
diaza-1,3-butadiene (9b): E/Z ratio after equilibration (%) =
84:16. 1H NMR (500 MHz, CDCl3) 7.85 (d, J = 8.0 Hz, 2H, Z),
7.78 (m, 2H, E), 7.49-7.46 (m, 3H E+3H Z), 7.38 (d, J = 13.4 Hz,
1H, E), 7.25 (dd, J = 8.2 Hz, J = 1.0 Hz, 1H, Z), 6.82 (ddd, J =
9.0 Hz, J = 6.0 Hz, J = 1.0 Hz, 1H, Z), 6.78 (dd, J = 13.7, J = 7.8
Hz, 1H, E), 6.18 (dd, J = 9.0 Hz, J = 8.2 Hz, 1H, Z), 5.72 (t, J =
7.2 Hz, 1H, E), 5.56 (dd, J = 6.0, J = 4.5 Hz, 1H, Z), 5.50-5.47
(m, 2H, E), 5.41 (ddd, J = 6.5, J = 5.0 Hz, J = 4.5 Hz, 1H, Z),
4.29 (dd, J = 11.8, J = 5.0 Hz, 1H, E), 4.23 (dd, J = 11.5, J = 5.0
Hz, 1H, Z), 4.13 (dd, J = 11.5, J = 6.5 Hz, 1H, Z), 4.04 (dd, J =
11.9, J = 6.2 Hz, 1H, E), 2.11 (s, 3H, E), 2.10 (s, 3H, E), 2.09 (s,
3H, E), 2.08 (s, 3H, Z), 2.07 (s, 3H, E), 2.04 (s, 3H, Z), 2.02 (s,
3H, Z); 13C NMR (125 MHz, CDCl3) 170.4 (E), 170.0 (E), 169.9
(Z), 169.8 (Z), 169.4 (Z), 152.5 (Z), 152.3 (E), 151.2 (E), 148.4
(Z), 135.8 (E), 131.8 (Z), 131.5 (E), 129.1 (E+Z), 123.3 (Z),
122.9 (E), 70.8 (E+Z), 69.1 (E), 68.5 (Z), 68.1 (E), 67.1 (Z), 61.9
(Z), 61.8 (E), 20.9 (E+Z), 20.8 (E+Z), 20.7 (E+Z).
Photoisomerization of (1E,3E)-1,2-diaza-1,3-butadienes (4a-
9a) into (1Z,3E)-1,2-diaza-1,3-butadienes (4c-9c): All samples
were prepared by dissolving (1E,3E)-azoalkenes (0.1 g) in
1
benzene (0.5 mL). Their evolution was monitored by H NMR
spectroscopy after 1 h of irradiation with sunlight. Formation of
the corresponding (1Z,3E) isomers could be observed; structural
assignment and peak identification of each isomer were
performed as follows:
Mixture of Compounds (1E,3E)-4-(tetra-O-acetyl-D-arabino-
tetritol-1-yl)-1-(4-methylphenyl)-1,2-diaza-1,3-butadiene (6a)
and
(1Z,3E)-4-(tetra-O-acetyl-D-arabino-tetritol-1-yl)-1-(4-
methylphenyl)-1,2-diaza-1,3-butadiene (6c): E/Z ratio after
equilibration (%) = 93:7. 1H NMR (500 MHz, C6D6) 7.83 (d, J =
8.5 Hz, 2H, arom, E), 7.63 (dd, J(1,2) = 13.5, J(1,3) = 1.5 Hz,
1H, H-1, E), 7.32 (dd, J(1,2) = 13.5, J(1,3) = 1.0 Hz, 1H, H-1, Z),
6.91 (d, J = 8.5 Hz, 2H, arom, E), 6.86 (dd, J(1,2) = 13.5, J(2,3)
= 6.0 Hz, 1H, H-2, E), 6.79 (dd, J(1,2) = 13.5, J(2,3) = 6.0 Hz,
1H, H-2, Z), 6.05 (ddd, J(2,3) = 5.5, J(3,4) = 3.0, J(1,3) = 1.5 Hz,
1H, H-3, E), 5.76 (ddd, J(2,3) = 5.5, J(3,4) = 3.0, J(1,3) = 1.5 Hz,
1H, H-3, Z), 5.63 (dd, J(4,5) = 9.0, J(3,4) = 3.0, 1H, H-4, E), 5.52
(dd, J(4,5) = 9.0, J(3,4) = 3.0, 1H, H-4, Z), 5.47 (ddd, J(4,5) =
9.0, J(5,6’) = 6.0, J(5,6) = 3.0 Hz, 1H, H-5, E), 5.39 (ddd, J(4,5)
= 9.0, J(5,6’) = 6.0, J(5,6) = 3.0 Hz, 1H, H-5, Z), 4.27 (dd, J(6,6’)
= 12.5, J(5,6) = 3.0 Hz, 1H, H-6, E), 4.22 (dd, J(6,6’) = 12.5,
J(5,6) = 3.0 Hz, 1H, H-6, Z), 4.17 (dd, J(6,6’) = 12.5, J(5,6’) = 5.0
Hz, 1H, H-6’, E), 4.12 (dd, J(6,6’) = 12.5, J(5,6’) = 5.0 Hz, 1H, H-
6’, Z), 1.97 (s, 3H, CH3, E), 1.78 (s, 3H, CH3, E), 1.71 (s, 3H,
CH3, E), 1.70 (s, 3H, CH3, E), 1.57 (s, 3H, CH3, E); 13C NMR
Mixture of Compounds (1E,3E)-4-(tetra-O-acetyl-D-arabino-
tetritol-1-yl)-1-phenyl-1,2-diaza-1,3-butadiene
(4a)
and
(1Z,3E)-4-(tetra-O-acetyl-D-arabino-tetritol-1-yl)-1-phenyl-1,2-
diaza-1,3-butadiene (4c): E/Z ratio after equilibration (%) =
1
90:10. H NMR (500 MHz, C6D6) 7.86 (m, 2H, arom, E), 7.60
(dd, J(1,2) = 13.5, J(1,3) = 1.5 Hz, 1H, H-1, E), 7.23 (dd, J(1,2) =
13.5, J(1,3) = 1.5 Hz, 1H, H-1, Z), 7.08 (m, 2H, arom, E), 7.03
(m, 1H, E), 6.95 (m, 2H, arom, Z), 6.93 (dd, J(1,2) = 13.5, J(1,3)
= 6.0 Hz, 1H, H-2, Z), 6.88 (dd, J(1,2) = 13.5, J(1,3) = 5.5 Hz,
1H, H-2, E), 6.81 (m, 1H, arom, Z), 6.68 (m, 1H, arom, Z), 6.04
(ddd, J(2,3) = 5.5, J(3,4) = 3.0, J(1,3) = 1.5 Hz, 1H, H-3, E), 5.74
(ddd, J(2,3) = 6.0, J(3,4) = 3.0, J(1,3) = 1.5 Hz, 1H, H-3, Z), 5.62
(dd, J(4,5) = 9.0, J(3,4) = 3.0 Hz, 1H, H-4, E), 5.50 (dd, J(4,5) =
8.5, J(3,4) = 3.0 Hz, 1H, H-4, Z), 5.46 (ddd, J(4,5) = 9.0, J(5,6’) =
5.0, J(5,6) = 3.0 Hz, 1H, H-5, E), 5.37 (ddd, J(4,5) = 9.0, J(5,6’)
15
This article is protected by copyright. All rights reserved.